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Abstract 
Background: Madagascar, as other malaria endemic countries, depends mainly on international funding for the 
implementation of malaria control interventions (MCI). As these funds no longer increase, policy makers need to 
know whether these MCI actually provide the expected protection. This study aimed at measuring the effectiveness 
of MCI deployed in all transmission patterns of Madagascar in 2012–2013 against the occurrence of clinical malaria 
cases.
Methods: From September 2012 to August 2013, patients consulting for non-complicated malaria in 31 sentinel 
health centres (SHC) were asked to answer a short questionnaire about long-lasting insecticidal nets (LLIN) use, indoor 
residual spraying (IRS) in the household and intermittent preventive treatment of pregnant women (IPTp) intake. 
Controls were healthy all-ages individuals sampled from a concurrent cross-sectional survey conducted in areas sur-
rounding the SHC. Cases and controls were retained in the database if they were resident of the same communes. The 
association between Plasmodium infection and exposure to MCI was calculated by multivariate multilevel models, 
and the protective effectiveness (PE) of an intervention was defined as 1 minus the odds ratio of this association.
Results: Data about 841 cases (out of 6760 cases observed in SHC) and 8284 controls was collected. The regular use 
of LLIN provided a significant 51 % PE (95 % CI [16–71]) in multivariate analysis, excluding in one transmission pattern 
where PE was −11 % (95 % CI [−251 to 65]) in univariate analysis. The PE of IRS was 51 % (95 % CI [31–65]), and the 
PE of exposure to both regular use of LLIN and IRS was 72 % (95 % CI [28–89]) in multivariate analyses. Vector control 
interventions avoided yearly over 100,000 clinical cases of malaria in Madagascar. The maternal PE of IPTp was 73 %.
Conclusions: In Madagascar, LLIN and IRS had good PE against clinical malaria. These results may apply to other 
countries with similar transmission profiles, but such case–control surveys could be recommended to identify local 
failures in the effectiveness of MCI.
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Background
Malaria control has been intensified in the last dec-
ade, leading to an important reduction in its incidence 
[1]. In Madagascar, the incidence of clinical malaria in 
outpatient wards declined by 81  %, in inpatient wards 
by 69  % and mortality by 75  % between 2000 and 2010 
[2]. This reduction in malaria burden could be attrib-
uted to the intensification and scale up of malaria con-
trol interventions (MCI), but it remains unknown what 
part of this decline was attributable to the MCIs. It is 
also not known which intervention(s) within the pack-
age is(are) most effective [3]. Moreover, other factors 
may have played a role that would balance the optimism 
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arising from this success, e.g. increase of urbanization 
[4], climate change [5], and changes in socio-economic 
factors [6]. Roll-out of rapid diagnostic tests (RDT) may 
cause a false impression of decline in incidence because 
false positive cases—formerly diagnosed on the sole base 
of symptoms—are excluded from cases count [7]. Now 
that international funding for malaria control stopped 
increasing, it becomes of public health and strategic 
importance to measure the actual effectiveness of MCIs, 
in order to fund what is really working. In this context, 
the present study was aimed to evaluate whether inter-
ventions actually deployed performed well by measuring 
their individual effectiveness, their coverage and, by mul-
tiplication of these two values, their community effective-
ness [8, 9]. Although the level of evidence generated by 
observational studies don’t reach the one generated by 
randomized controlled trials (RCTs) it would be unethi-
cal to conduct RCTs—and thus intentionally leave indi-
viduals unprotected—for policy guidance.
The study was named MEDALI—a French acronym 
standing for Mission d’Etude des Déterminants de l’Accès 
aux Méthodes de Lutte antipaludique et de leur Impact—
and took place in Madagascar in 2012–2013. The design 
and methodology of the overall MEDALI project has 
been previously described [10]. The primary objec-
tive of the study presented here was the evaluation of 
the effectiveness against incidence of non-complicated 
clinical malaria of long-lasting insecticidal nets (LLIN) 
and indoor residual spraying (IRS) in the overall popu-
lation. The secondary objective was the evaluation of 
the effectiveness against incidence of non-complicated 
clinical malaria of intermittent preventive treatment in 
pregnancy (IPTp) in a population of pregnant women or 
women having recently delivered.
Methods
Study design
Districts of Madagascar are divided into five main opera-
tional zones (Fig. 1), which correspond to the transmis-
sion patterns of Madagascar [11]. The two coastal regions 
exhibit hyperendemic patterns with a transmission last-
ing all year in the East and more than 6 months per year 
in the West. In the central highlands, the transmission is 
unstable, and episodic or epidemic. In the fringe areas, 
i.e. at intermediate altitudes, the transmission pattern is 
seasonal, lasting from November to May (rainy season). 
In the South, the period of transmission is short and epi-
sodic. Fringe, central highlands and South are prone to 
outbreaks.
The selection of study sites was based on a network 
of sentinel health centres (SHC) for surveillance of 
fever-associated diseases that has been established in 
order to cover all the ecosystems of Madagascar [12]. 
Each location where at least one SHC existed in 2012 
was included in the study, thus defining 31 study sites. 
All malaria transmission patterns were represented: 13 
sites were located in the Western transmission pattern, 
seven in the East, five in the Fringe, four in the Central 
Highlands and two in the South (Fig. 1). These patterns 
encompass respectively 21.0, 27.5, 13.7, 31.9 and 5.9 % of 
Malagasy population. The design consisted in recruiting 
non-complicated clinical malaria cases in health facilities 
belonging to the SHC network, and controls in the popu-
lation living in their catching same areas.
Inclusion of cases
All 31 SHCs were proposed to participate in the study 
protocol. In the participating SHCs, patients present-
ing with clinical malaria cases or their tutors were asked 
to answer a short one-page questionnaire about socio-
demographic data and exposure to MCIs: LLIN, IRS 
and IPTp. Inclusion criteria were (1) fever, i.e., axillary 
temperature ≥37.5  °C [13] or self-reported symptoms 
of fever; (2) RDT or microscopy positive for any Plasmo-
dium species; (3) age ≥6 months; and (4) informed con-
sent of the patient or his/her tutor. CareStart® Malaria 
RDT (Access Bio Inc., Monmouth Junction (NJ), USA) 
was used, which is the RDT commonly used in the pub-
lic health system in Madagascar. Cases were retained in 
the database if they came from the same commune as 
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Fig. 1 SHC and malaria transmission patterns in Madagascar
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Inclusion of controls
Controls were selected from a cross-sectional survey 
(CSS), which took place in the same areas in the context 
of the very same MEDALI project, between September 
2012 and January 2013. The methodology of this CSS has 
been previously described [10]. Briefly, it was a cross-
sectional household survey in which a two-stage cluster 
sampling technique was used to randomly select two 
fokontanys (smallest administrative subdivision in Mada-
gascar) near each SHC. In each fokontany, the investiga-
tors followed a random path to include 50 households, 
i.e. approximately 225 individuals per site. The sample 
size of controls was calculated for a concomitant cross-
sectional survey, leaving controls in excess [10, 14, 15]. 
Heads of households and all members of the household 
eligible for the survey were interviewed about socio-
demographic features and exposure to MCIs, their axil-
lary temperature was measured, and a RDT (CareStart® 
Malaria) was performed. Inclusion criteria were: (1) age 
≥6  months, (2) having signed individual informed con-
sent including agreement for blood sampling, and (3) 
being able to take a per os treatment in case of positive 
RDT. Parents or tutors signed and answered the ques-
tionnaire for minors and impaired individuals. Controls 
were retained in the database if they came from the same 
commune as cases, if they were permanent residents of 
the household, and if they had no malaria at the time of 
survey (i.e. fever or history of fever, and RDT or micros-
copy positive for any Plasmodium species), or in the last 
3  months (i.e. diagnosis of malaria, or history of fever 
treated with anti-malarial drugs, or history of fever with 
unknown management).
Sample size calculation
The primary objective for sample size calculation was 
to detect the association between occurrence of clinical 
malaria due to any Plasmodium species, and exposure to 
MCI. It was assumed that at least three controls would be 
found for each case. A sample size of 800 cases and 2400 
controls has a power of 87, 70, and 49 % for detecting OR 
of 0.7, 0.75 and 0.8, respectively, considering the follow-
ing parameters: coverage of intervention of 50 % in con-
trols, cluster effect of 2, and alpha risk of 5 % [16].
Data management and statistical analyses
Bed net use was defined as “use every night during last 
3  months” because it is more stringent than the “last 
night” definition [10, 14]. The association between expo-
sure to MCIs and being a case was estimated by gener-
alized estimating equations models (GEE) taking into 
account an exchangeable within-site correlation struc-
ture using gee function on R software [17]. GEE models 
allow for a robust estimation of ORs and their confidence 
intervals while controlling for clustering [9]. Controls 
were neither matched with cases nor limited to three 
controls per case, but adjustment variables (age, sex, and 
transmission pattern) were forced in all models. All mul-
tivariate model fits were evaluated using binned residual 
plots [18, 19]. Whether malaria transmission pattern, age 
less than 5  years, or season of detection of cases influ-
enced the effectiveness of MCI was tested by introducing 
interaction terms in the models. Whenever season modi-
fied the effectiveness measured, the analysis was rerun on 
the cases that occurred in the same quarter as the collec-
tion of data on controls. The protective effectiveness (PE) 
of an intervention was defined as 1 minus the odds ratio 
of the exposure to this intervention as suggested previ-
ously [8].
Estimation of the number of clinical cases of malaria 
avoided
In order to evaluate the number of clinical cases of 
malaria prevented by each MCI with significant PE, 
the PE value was first multiplied by the coverage of the 
MCI in the general population, thus giving the propor-
tion of cases avoided or “community effectiveness” (CE), 
as described previously [8]. The estimated number of 
cases avoided was defined as the annual number of clini-
cal cases multiplied by CE/(1  −  CE). Coverage values 
were extracted from the concomitant CSS mentioned 
previously [10], and number of malaria cases in 2011 by 
districts was provided by the National Malaria Control 
Programme.
Ethical considerations
All surveys followed ethical principles according to the 
Helsinki Declaration. Informed consent was obtained 
from the individuals, or the parents/tutors of the chil-
dren before inclusion. The protocol was approved by 
the National Ethic Committee of the Ministry of Public 
Health of Madagascar (approval #CNE 57/MSANP/CE of 
July 24th, 2012).
Results
From September 2012 to August 2013, 6760 clinical 
malaria cases were observed in 30 SHCs. Four SHC did 
not participate and one had no malaria cases during the 
period (Figs.  1, 2). Among the remaining 6413 cases, 
1582 questionnaires (24.7 %) were filled. The proportion 
of refusals among missing questionnaires is unknown. 
Individuals coming from the same communes as indi-
viduals included in the CSS accounted for 58.3 % of the 
questionnaires sent. Among those, 841 questionnaires 
(91.1 %) were correctly filled, from 24 SHC (Fig. 2). Over-
all, 34 clusters (communes) were identified in all trans-
mission patterns: 61.4  % of cases occurred in the West, 
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Fig. 2 Flow diagram
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30.0 % in the East, 6.9 % in the Fringe, 1.0 % in the South, 
and 0.8 % in the Highlands. The mean number of clini-
cal malaria cases per cluster was 24.7 individuals (range 
1–179). These episodes occurred between the end of 
September 2012 and mi-June 2013: 39.3  % in spring, 
i.e. before December 31st, 2012; 47.8  % in summer, i.e. 
between January 1st and March 31st, 2013; and 12.9 % in 
fall, i.e. after April 1st, 2013.
In a population of 18,921 individuals, 15,476 were 
included in the CSS [10, 14]. Among those, 6231 (40.3 %) 
were not comparable to cases since they were located in 
other communes, and 274 (1.8  %) were not permanent 
resident of the households where they had been identified. 
Of the remaining 8971 individuals, 42 (0.5 %) had an ongo-
ing malaria episode and 645 (7.2 %) described a history of 
fever within the last 3 months that was compatible with an 
episode of malaria (Fig. 2). The study ended up with a data-
base of 841 cases and 8284 controls, dispatched in 34 clus-
ters (communes). The majority of the sample was from the 
Western transmission pattern (61.4 % of cases, 52.2 % of 
controls), then came the East (30.0 % of cases and 26.5 % of 
controls), and Fringe (6.9 % of cases and 8.1 % of controls); 
the Highlands and the Southern transmission patterns 
encompassed seven and eight cases only (representing 0.8 
and 1.0 % of cases, respectively) and their controls repre-
sented 8.1 and 5.1 % of controls, respectively.
Bed nets
In the areas where LLIN are distributed, i.e. Eastern, 
Western, Southern, and Fringe transmission patterns, the 
sample encompassed 31 clusters including 834 cases and 
7617 controls. The use of LLIN every night was higher 
in controls (53.2 %) than in cases (39.3 %), and provided 
a significant 53 % PE (95 % CI [20–73]) in bivariate and 
50  % (95  % CI [16–70]) in multivariate analyses (Addi-
tional file  1). No significant interaction term was found 
between the season or the age under than 5  years old, 
and LLIN use. LLIN use among cases decreased from 
43.3 % in spring, to 37.4 % in summer, and to 34.4 % in 
fall, but this difference was not significant (Fisher’s exact 
test, p > 0.1). A significant interaction term between the 
southern transmission pattern and LLIN use was identi-
fied (p < 0.001), and separate analyses were conducted for 
the South and the rest of target zones. In the South, the 
association between LLIN use and clinical malaria was 
non- significant (OR 1.11, 95 % CI [0.35–3.51]) in bivari-
ate analysis. The small number of cases (n  =  8) in the 
South precluded the possibility to conduct a multivariate 
analysis. In all other areas targeted by LLIN distribution 
campaigns, the use of LLIN every night provided a sig-
nificant 51 % PE (95 % CI [16–71], Table 1), and the use 
of non-impregnated bed net (NIBN) a significant 37 % PE 
in multivariate analysis (95 % CI [6–58], Table 1).
IRS
IRS campaigns took place in the Fringe, in most of High-
lands, and in certain parts of Western and Southern 
transmission patterns. In these areas, living in a house-
hold that had been sprayed within the last 12  months 
provided a significant 54 % PE in bivariate and multivari-
ate analyses (95 % CI [30–70] and [36–68], respectively). 
Models were run on a database of 11 clusters, including 
199 cases and 2680 controls. No significant interaction 
term between the age under than 5  years old, or trans-
mission pattern, and exposure to IRS was found. IRS 
coverage in the previous year among cases significantly 
decreased from 72.5 % in the spring, to 43.5 % in the sum-
mer, and to 4.8 % in the fall (Fisher’s exact test, p < 0.001). 
Interaction terms between season and IRS were also 
significant (p  <  0.001), and the final models were thus 
restricted to cases having occurred in the spring of 2012. 
In this analysis, 179 cases and 1125 controls belonging to 
five clusters in the Fringe, Western and Southern trans-
mission patterns were analyzed. The PE of IRS was 50 % 
in bivariate analysis (95 % CI [24–67]) and 51 % in multi-
variate analysis (95 % CI [31–65], Table 2).
Concurrent exposure to IRS and LLIN
Given the above reported interactions, the analysis was 
restricted to cases occurring in the spring of 2012, and 
excluded the Southern transmission pattern, resulting 
in a sub-sample comprising four clusters, 173 cases and 
916 controls in the Fringe and Western transmission pat-
terns. In these clusters where IRS campaigns and LLIN 
distributions occurred, being exposed to both MCI pro-
vided a significant 72  % PE in bivariate and multivari-
ate analyses (95 % CI [22–90] and [28–89], respectively, 
Table 3). There was some association between exposure 
to both intervention and exposure to a single interven-
tion, but it did not reach the significance threshold (OR 
against LLIN alone 0.75, 95 % CI [0.54–1.04], p = 0.082, 
and OR against IRS alone 0.63, [0.38–1.06], p = 0.082).
IPTp
In Madagascar, IPTp is proposed in all transmission pat-
terns except in the Highlands. In these areas, having 
taken at least one dose of IPTp during pregnancy pro-
vided a 78  % PE in bivariate analysis and a 73  % PE in 
multivariate analysis, but these results were not statisti-
cally significant (Table 4).
Estimation in the number of clinical malaria cases avoided 
by LLIN and IRS at the country level
Considering number of malaria cases provided by 
National Malaria Control Programme for 2011 and cov-
erage from the CSS mentioned previously [10], these 
interventions could have saved over 100,000 clinical 
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malaria cases in one year (Table  5), 88  % by LLIN and 
12 % by IRS.
Discussion
During the last decade, Madagascar has started and 
scaled up various interventions and policy changes 
regarding malaria control, resulting in dramatic decline 
in malaria burden, but the impact of each MCI cannot be 
disentangled by ecological studies [3]. This case–control 
study provided reliable information for guidance in policy 
making. In this study, vector control interventions dem-
onstrated important and significant PE: LLIN provided a 
51 % PE (95 % CI 16–71 %) and IRS a 51 % PE (95 % CI 
31–65) when controlling for major confounding variables.
Table 1 Bi- and  multivariate analyses of  risk factors for  developing a clinical malaria episode, including  bed net use, 
in multivariate analyses, in zones targeted for LLIN distribution excluding the Southern transmission pattern (826 cases, 
7192 controls, 29 communes)
Variable Category N cases (%) N controls (%) Bivariate Multivariate
Crude OR [95 %CI] p Adjusted OR [95 %CI] p
Every night bed net use LLIN 326 (39.5) 3959 (55.0) 0.47 [0.27–0.80] 0.005 0.49 [0.29–0.84] 0.009
NIBN 84 (10.2) 857 (11.9) 0.62 [0.40–0.95] 0.029 0.63 [0.42–0.94] 0.023
None 416 (50.4) 2376 (33.0) 1.00 1.00
Age group 0–1 year 56 (6.8) 302 (4.2) 3.42 [1.53–7.64] 0.003 3.29 [1.45–7.48] 0.004
2–4 years 113 (13.7) 771 (10.7) 2.93 [1.66–5.17] <0.001 2.72 [1.51–4.90] <0.001
5–9 years 175 (21.2) 1228 (17.1) 2.70 [1.79–4.06] <0.001 2.44 [1.63–3.65] <0.001
10–15 years 169 (20.5) 1051 (14.6) 2.97 [2.12–4.14] <0.001 2.57 [1.85–3.58] <0.001
15–19 years 122 (14.8) 762 (10.6) 3.01 [1.93–4.69] <0.001 2.49 [1.66–3.75] <0.001
20–39 years 137 (16.6) 1784 (24.8) 1.67 [0.98–2.87] 0.061 1.57 [0.93–2.65] 0.088
≥40 years 54 (6.5) 1294 (18.0) 1.00 1.00
Sex Male 447 (54.1) 3114 (43.3) 1.00 1.00
Female 379 (45.9) 4078 (56.7) 0.64 [0.53–0.78] <0.001 0.74 [0.62–0.87] <0.001
Transmission pattern East 252 (30.5) 2194 (30.5) 1.10 [0.16–7.55] 0.923 1.90 [0.24–15.13] 0.542
Fringe 58 (7.0) 670 (9.3) 1.00 1.00
West 516 (62.5) 4328 (60.2) 1.41 [0.27–7.44] 0.686 1.46 [0.22–9.60] 0.696
Table 2 Bi- and multivariate analyses of risk factors for developing a clinical malaria episode, including IRS the previous 
year in the household (179 cases, 1125 controls, 5 communes)
Variable Category N cases (%) N controls (%) Bivariate Multivariate
Crude OR [95 %CI] p Adjusted OR [95 %CI] p
IRS the previous year No 92 (51.4) 778 (69.2) 0.50 [0.33–0.76] 0.001 0.49 [0.35–0.69] <0.001
Yes 87 (48.6) 347 (30.8) 1.00 1.00
Age group 0–1 year 19 (10.6) 37 (3.3) 26.08 [12.00–56.71] <0.001 20.76 [9.44–45.66] <0.001
2–4 years 34 (19.0) 130 (11.6) 14.24 [6.12–33.16] <0.001 12.85 [5.77–28.63] <0.001
5–9 years 38 (21.2) 198 (17.6) 11.17 [5.39–23.16] <0.001 9.69 [5.07–18.52] <0.001
10–15 years 26 (14.5) 180 (16.0) 7.33 [2.08–25.90] 0.002 6.44 [2.03–20.41] 0.002
15–19 years 26 (14.5) 125 (11.1) 11.29 [3.57–35.67] <0.001 10.03 [3.93–25.58] <0.001
20–39 years 33 (18.4) 247 (22.0) 7.34 [2.77–19.43] <0.001 6.45 [2.81–14.81] <0.001
≥40 years 3 (1.7) 208 (18.5) 1.00 1.00
Sex Male 98 (54.7) 476 (42.3) 1.00 1.00
Female 81 (45.3) 649 (57.7) 0.59 [0.52–0.66] <0.001 0.65 [0.55–0.78] <0.001
Transmission pattern Fringe 55 (30.7) 219 (19.5) 1.00 1.00
West 118 (65.9) 697 (62.0) 0.61 [0.25–1.47] 0.269 1.50 [0.71–3.14] 0.288
South 6 (3.4) 209 (18.6) 0.11 [0.11–0.11] <0.001 0.13 [0.12–0.14] <0.001
Page 7 of 10Kesteman et al. Malar J  (2016) 15:83 
Deployment of LLIN and IRS may have prevented 
100,000 cases annually. Note that IRS in Madagascar is 
mainly deployed in low-transmission settings and LLIN 
in almost all the country, which explains why the number 
of prevented cases differs so much between the two MCI 
while PE are similar. Even though it may be regarded as 
simplistic to add cases avoided by LLIN to cases avoided 
by IRS, these results give a rough overview of the number 
of prevented cases, and they could feed more sophisti-
cated cost-effectiveness or transmission models.
The present results are close to results from a simulta-
neous CSS survey aimed at estimating the effectiveness 
of MCI against Plasmodium infection where LLIN was 
found to have a 41 % PE, IRS had a 44 % PE at household 
level in certain places, the concurrent exposure to both 
LLIN and IRS had a 86 % PE, and IPTp a 65 % PE [14, 15]. 
This suggests that measuring the effectiveness of MCI 
for one outcome, e.g. malaria infection is a reasonable 
proxy for the other, e.g. clinical malaria. As observed in 
the study mentioned above, the southern part of Mada-
gascar appears to be different from the other zones, but 
the present study lacked statistical power to evaluate the 
effectiveness of LLIN in this transmission pattern since 
the sample size of cases was eight only.
The results from the present study are also in line with 
results from efficacy studies of LLIN and IRS, which sug-
gests that the efficacy of MCI is preserved in Madagascar. 
In meta-analyses, insecticides-treated nets (ITN) were 
shown to provide a 50 % PE against malaria incidence as 
compared to no nets in areas of stable malaria, and a 62 % 
PE in areas of unstable malaria [20], and the PE of IRS 
ranged between 31 and 88 % in areas of unstable malaria 
[21]. Nevertheless, in contrast with these studies, the pre-
sent results show no relationship between transmission 
patterns and MCI effectiveness. This might be explained 
by an insufficient statistical power in the present study to 
detect such a difference, since few cases have been identi-
fied in low-transmission areas. In the present study, the 
Table 3 Bi- and  multivariate analyses of  risk factors for  developing a clinical malaria episode, including  bed net use 
and IRS (134 cases, 749 controls, 4 communes)
Variable Category N cases (%) N controls (%) Bivariate Multivariate
Crude OR [95 %CI] p Adjusted OR [95 %CI] p
Every night bed net use 
and/or IRS the previous 
year
LLIN use and IRS 28 (16.2) 335 (36.6) 0.28 [0.10–0.78] 0.015 0.28 [0.11–0.72] 0.008
No LLIN use and IRS 60 (34.7) 317 (34.6) 0.43 [0.25–0.74] 0.003 0.44 [0.26–0.74] 0.002
LLIN use and no IRS 12 (6.9) 97 (10.6) 0.34 [0.10–1.11] 0.073 0.37 [0.11–1.25] 0.110
NIBN use and no IRS 6 (3.5) 18 (2.0) 1.00 [0.78–1.30] 0.972 0.90 [0.75–1.09] 0.287
No bed net use and no IRS 67 (38.7) 149 (16.3) 1.00 1.00
Age group 0–1 year 19 (11.0) 31 (3.4) 5.69 [3.35–9.69] <0.001 4.78 [2.56–8.92] <0.001
2–4 years 33 (19.1) 96 (10.5) 3.12 [2.33–4.18] <0.001 3.02 [1.96–4.65] <0.001
5–9 years 38 (22.0) 152 (16.6) 2.49 [1.95–3.19] <0.001 2.38 [1.81–3.12] <0.001
10–15 years 23 (13.3) 148 (16.2) 1.36 [0.83–2.23] 0.218 1.27 [0.70–2.31] 0.440
15–19 years 24 (13.9) 111 (12.1) 2.17 [1.52–3.09] <0.001 1.97 [1.48–2.62] <0.001
≥20 years 36 (20.8) 378 (41.3) 1.00 1.00
Sex Male 94 (54.3) 386 (42.1) 1.00 1.00
Female 79 (45.7) 530 (57.9) 0.59 [0.54–0.66] <0.001 0.68 [0.56–0.83] <0.001
Transmission pattern Fringe 55 (31.8) 219 (23.9) 1.00 1.00
West 118 (68.2) 697 (76.1) 0.61 [0.25–1.47] 0.268 1.14 [0.94–1.38] 0.196
Table 4 Bi- and multivariate analyses of risk factors for developing a clinical malaria episode, including IPTp
Transmission patterns could not be included because it caused the model not to converge (12 cases, 110 controls, 5 communes)
Variable Category N cases (%) N controls (%) Bivariate Multivariate
Crude OR [95 %CI] p Adjusted OR [95 %CI] p
≥1 dose IPTp Yes 3 (25.0) 11 (57.9) 0.22 [0.04–1.29] 0.093 0.27 [0.04–1.89] 0.187
No 9 (75.0) 8 (42.1) 1.00 1.00
Age group 15–24 years 11 (91.7) 8 (42.1) 14.24 [4.02–50.38] <0.001 12.35 [3.90–39.11] <0.001
25–49 years 1 (8.3) 11 (57.9) 1.00 1.00
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age under 5 years was not associated with a better effec-
tiveness of MCI, while this is theoretically expected [22] 
and observed in some efficacy studies [23].
This study design was suggested more than a decade 
ago in order to monitor the effectiveness of MCI through 
time and space [8, 9], but relatively few surveys have been 
conducted. The scarceness of CCS is surprising given the 
relative simplicity of the survey design and importance of 
the information it provides in terms of policy guidance. 
If vector control interventions are consider, for example, 
only 13 CCS have tried to measure the PE of ITN [9, 24–
34], and four the PE of IRS—including two of the previ-
ous [24, 25, 35, 36]. Only six of these 15 surveys collected 
data in a geographical region of the size of a district or 
above, and their sample sizes were smaller (mean num-
ber of cases 219, range 35–534), which makes the present 
study the biggest CCS ever aimed at evaluating the effec-
tiveness of MCI, with a unique countrywide design.
Nine of the CCS mentioned above found a significant 
PE of ITN. As compared with these studies, the use of 
bed net was defined more restrictively, i.e. the use every 
night in the last 3  months instead of the use last night. 
This definition was selected in order to provide a more 
accurate estimation of the effectiveness in the perspec-
tive of being used for mathematical modelling or for cal-
culation of the cost-effectiveness ratio. Indeed, the “last 
night” definition is more sensitive to social desirability 
bias and clerical errors, and tends to overestimate the 
coverage [10].
This study presents several limitations. One of the main 
issues is that a minimal questionnaire was used in order 
to facilitate the practitioners’ task, preventing us from 
collecting useful data such as socioeconomic status or 
education level for adjustment of multivariate models. 
Nevertheless, in a concurrent study aimed at evaluating 
the effectiveness of the very same MCI against infection 
through a CSS design, the difference between crude and 
adjusted OR were trivial.
The results of the study might have underestimated the 
actual effectiveness of LLIN and IRS for four reasons. 
Firstly, the study design does not allow for calculation of 
herd protection offered by vector control interventions 
while some authors claim that the protection offered 
by these interventions is more visible at the community 
than at the individual or household level, especially IRS 
[37]. Secondly, the survey did not cover the period dur-
ing which IRS is expected to have an effect on vectors, 
i.e. a few months after spraying [38]. The previous IRS 
campaigns took place in November–December 2011, 
and one happened at the end of the period of data collec-
tion, in March–April 2013. The latter campaign was sup-
posed to take place in November–December 2012, but 
was delayed. The low coverage (i.e. household sprayed 
last 12 months) of cases in summer might thus reflect a 
long interval since the previous IRS campaign, and the 
PE derived from these cases is probably not reliable. 
The most comparable cases with controls are definitely 
those who have been identified in the spring of 2012, i.e. 
at the same moment as the CSS. When the analysis was 
restrained to these individuals, the PE of IRS was dem-
onstrated. As other authors have shown, the duration of 
the bio-efficacy of IRS was not expected to last more than 
6–8 months [38], but its impact on malaria incidence may 
remain after the disappearance of the insecticide effect 
[14, 39, 40]. Third, LLIN use in controls was estimated in 
a season where bed net use was low [10, 41]. Neverthe-
less, non-significant interaction terms indicate that sea-
son did not influence the measure of the effectiveness of 
LLIN. Fourth, a recall bias might have occurred, as for all 
case–control studies. If cases better recalled exposure to 
MCIs, or if memory failures occurred in both cases and 
controls, then hypothesis tests would be biased towards 
the null [42].
Another limitation is the selection of cases and con-
trols. In a theoretical database of over 6000 malaria 
cases, only 841 were retained, mainly because 
Table 5 Estimation of the annual number of clinical malaria cases prevented by vector control interventions in Madagas-
car





LLIN IRS Total N cases 
prevented
PE (%) Cov. (%) CE (%) N cases pre-
vented
PE (%) Cov. (%) CE (%) N cases pre-
vented
East 157,858 51 61.1 31 71,457 NA 3.8 NA NA 71,457
Fringe 8347 51 35.4 18 1839 51 58.6 30 3558 5397
West 40,068 51 55.7 28 15,898 51 18.3 9 4124 20,023
South 8481 −30 41.9 NA NA 51 67.8 35 4483 4483
Highlands 6297 NA 7.7 NA NA 51 43.1 22 1774 1774
Total 221,051 89,194 12,165 101,359
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practitioners who agreed to participate in the study did 
not systematically fill in questionnaires. Nevertheless, 
since the choice of submitting the questionnaire to the 
patient or not was likely not driven by the exposure to 
MCI or confounding factors related to the place, one can 
reasonably suppose that no systematic bias occurred. 
Regarding controls, they are not strictly comparable to 
cases since they have not been selected in the opera-
tional catchment population of SHC, i.e. the individu-
als who get to the SHC when they are affected by febrile 
illnesses, but in the geographical catchment population, 
i.e. living in the same commune as cases. Typically, cov-
erage of the three MCI investigated here were higher in 
less populated areas [10] who have a likely lower access 
to health facilities; this might have resulted in an overes-
timation of the effectiveness of MCI. Recruiting controls 
among non-malaria patients or persons accompanying 
patients seen in the same health structures as patients 
would avoid this bias.
Finally, the present study has serious limitations in its 
statistical power regarding IPTp since the sample sizes 
are small. Therefore, the non-significant OR of IPTp shall 
not be considered as reflecting a poor effectiveness but 
rather as the reflection of an insufficient statistical power. 
Moreover the short questionnaire did not allow for the 
collection of data about parity, which would have been 
preferable to adjust for. Similarly, the non-significant 
additional effect of both LLIN and IRS over one single 
intervention might be attributed to a lack of statistical 
power since the analysis has been conducted on a small 
subset of the whole database.
Despite these limitations, the strengths of this study—
its large sample size, its countrywide scale, and its pop-
ulation-wide representativeness—suggest that the results 
are valuable for policy guidance in Madagascar. They 
allow, for the first time, an estimation of the number of 
clinical cases that have avoided by preventive measures. 
That opens the way for cost-effectiveness analysis that 
could help the health authorities in the choice of funding 
the MCI.
Conclusions
The results of this study showed that, in Madagascar in 
2012, both LLIN and IRS provided good protective effec-
tiveness against clinical malaria. The study failed to prove 
that combining both MCI simultaneously might provide 
additional effect. However, combining these two vector 
control interventions might be indicated if the coverage 
or the effectiveness of one of them is problematic. The 
present study also could prompt stakeholders to fund 
operational research in other endemic countries, in order 
to verify the local performance of MCI by case–control 
approaches.
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